Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: Study protocol for a community randomized controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Eisele, Thomas P ^a   Silumbe, Kafula ^b   Finn, Timothy ^a   Chalwe, Victor ^c   Kamuliwo, Mukalwa ^d   Hamainza, Busiku ^d   Moonga, Hawela ^d   Bennett, Adam ^e   Yukich, Josh ^a   Keating, Joseph ^a   Steketee, Richard W ^f   Miller, John M ^b  

^a TULANE UNIVERSITY   (United States)

^b Chainama Hospital College Grounds   (Zambia)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d MINISTRY OF HEALTH   (Zambia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f PATH   (United States)

Author keywords

Dihydroartemisinin plus piperaquine; Malaria; Mass drug administration

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; RAIN; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; DRUG COMBINATION; PIPERAQUINE; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DIRECTLY OBSERVED THERAPY; DISEASE CONTROL; DISEASE TRANSMISSION; HEALTH CARE FACILITY; HOUSEHOLD; HUMAN; INCIDENCE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA; MALARIA RAPID TEST; METHODOLOGY; MICROSCOPY; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; SAMPLE SIZE; SCHOOL CHILD; SEASONAL VARIATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VECTOR CONTROL; ZAMBIA; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; MASS SCREENING; PARASITOLOGY; PROGRAM EVALUATION; RESIDENTIAL CARE; SEASON; TIME FACTOR; TRANSMISSION;

ANTIMALARIALS; ARTEMISININS; CATCHMENT AREA (HEALTH); CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; HEALTH FACILITIES; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALARIA; MASS SCREENING; PREVALENCE; PROGRAM EVALUATION; QUINOLINES; RESEARCH DESIGN; SEASONS; TIME FACTORS; TREATMENT OUTCOME; ZAMBIA;

EID: 84938907386     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0862-3     Document Type: Article

References (16)

1. Zambia Ministry of Health. National Malaria Control Programme Strategic Plan for FY 2011-2015: Consolidating malaria gains for impact. Lusaka: Zambia Ministry of Public Health; 2011
2. Chizema-Kawesha E, Miller JM, Steketee RW, Mukonka VM, Mukuka C, Mohamed AD, et al. Scaling up malaria control in Zambia: progress and impact 2005-2008. Am J Trop Med Hyg. 2010;83(3):480-8.
3. Larsen DA, Bennett A, Silumbe K, Hamainza B, Yukich JO, Keating J, et al. Population-wide malaria testing and treatment with rapid diagnostic tests and artemether-lumefantrine in southern zambia: a community randomized step-wedge control trial design. Am J Trop Med Hyg. 2015;92(5):913-21.
4. World Health Organization (WHO). Guidelines for the treatment of malaria. 2nd ed. Geneva: WHO; 2010.
5. Cook J, Xu W, Msellem M, Vonk M, Bergstrom B, Gosling R, et al. Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis. 2015;211(9):1476-83.
6. Ashley EA, Stepniewska K, Lindegardh N, McGready R, Annerberg A, Hutagalung R, et al. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Trop Med Int Health. 2007;12(2):201-8.
7. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014;1:CD010927.
8. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. J Infect Dis. 2013;207(11):1637-45.
9. Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.
10. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.
11. McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings--can they find the last parasite? Clin Microbiol Infect. 2011;17(11):1624-31.
12. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003;19(10):452-60.
13. Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, Ogada E, et al. Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med. 2010;7(7):e1000304.
14. Zambia Ministry of Health. Guidelines on diagnosis and treatment of malaria in Zambia, 4th ed. Lusaka: Zambia Ministry of Public Health; 2014.
15. RBM. Guidelines for Core Population-based Indicators Calverton, Maryland, Roll Back Malaria, MEASURE Evaluation, World Health Organization, UNICEF: 2009.
16. Hayes RJ, Moulton LH. Cluster randomised trials. London, UK: Chapman & Hall/CRC Biostatistics Series; 2009.